All Type of News
Health insurance to screen eligibility of 1,880 OTCs
The government will evaluate the economic effectiveness of 1,880 OTC products from March to exclude items that are the least cost-effective from the second half of this yeasr, the Ministry of Health, Welfare and Famil...
Acetaminophen-containing OTCs to be hit by government plan
With the health ministry’s plans to screen the economic effectiveness of 1,880 OTC products, pharmaceutical firms having renowned drugs containing acetaminophen, such a Tylenol ER, will see their sales decline in the ...
Pharmacists calls for probe of antibiotic syrups
The Korean Pharmaceutical Association said on January 12 that it has asked the Korea Food and Drug Administration to re-investigate the stability profiles of 32 antibiotic syrups for children.
The associations said...
CrystalGenomics joins hands with AstraZeneca
CrystalGenomics Inc., a local biopharmaceutical company, services, said on January 12 that it has signed a contract with AstraZeneca Plc to jointly develop a new antibiotic to treat superbacteria.
Financial terms o...
LG Life Sciences signs drug export deal
LG Life Sciences, a local drug maker, said on January 12 that it has signed a contract with a China pharmaceutical company to export a newly developed substance for a drug to cure diabetes.
The deal with Beijing D...
Health insurance to cover cost-effective OTCs
The government plans to ask the national health insurance to cover only cost-effective over-the-counter (OTC) drugs to reduce medication costs.
The Ministry of Health, Welfare and Family Affairs has recently unveil...
Daily drug dispensing charges rise 100 won
Pharmacy’s daily drug dispensing charges this year rose 100 won from 3,740 won to 3,840 won, according to pharmaceutical business sources.
The daily drug dispensing charges include pharmacy management fee (550 won)...
GSK, Myungin cooperate
GlaxoSmithKline has joined hands with Myungin Pharm to market Paxil controlled release (CR) tablet and Seroxat (paroxetine) tablet through the execution of a co-promotion agreement.
Under the agreement, GSK and My...
Sanofi Pasteur Korea launches DTaP-IPV combo vaccines
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, says it has launched Tetraxim, a DTaP-IPV combined vaccine as a three-dose primary vaccination at 2, 4 and 6 months of age.
"Our DTaP vaccine will help...
Hanhwa veers into biosimilar market
Hanhwa Chemical, a unit of conglomerate Hanhwa, is entering the global bio-similar market together with Dream Pharma, a local biotech firm.
Hanwha is set to conduct Phase I trial of ‘HD203’ (etanercept) under the a...
